• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

各国针对新冠疫情的预防措施有效吗?一项对全球175个国家的评估研究。

Are countries' precautionary actions against COVID-19 effective? An assessment study of 175 countries worldwide.

作者信息

Alshammari Thamir M, Alenzi Khalidah A, Alnofal Fatemah A, Fradees Ghada, Altebainawi Ali F

机构信息

College of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia.

Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia.

出版信息

Saudi Pharm J. 2021 May;29(5):391-409. doi: 10.1016/j.jsps.2021.03.011. Epub 2021 Apr 20.

DOI:10.1016/j.jsps.2021.03.011
PMID:33897262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8056940/
Abstract

BACKGROUND

The coronavirus disease 2019 (COVID-19) pandemic has affected many countries negatively, particularly in terms of their health care and financial systems. Numerous countries have attempted to employ precautions to address this pandemic. This study was aimed at exploring and assessing the early precautionary actions taken by 175 countries on six continents to prevent the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

METHODS

An observational study utilizing available public data was conducted on the basis of data collected from December 31, 2019 until the end of April 2020 and then compared with data in January 2021. Several data were extracted, including information related to the date of the first reported case of SARS-CoV-2, total confirmed cases, total active cases and more. In addition, seven validated indicators were used to assess the countries' preparedness and precautionary actions.

RESULTS

A total of 175 countries were included in the study. The total COVID-19 infection rate increased exponentially and rapidly in North America and Europe from March to April. The application of precautions (indicators) varied between countries. School closures, quarantines and curfews were the most-applied indicators among all countries. As for the relationship between the indicators and their effects on the infection rate, Italy and Spain were the top countries in Europe and adopted all the indicators. Nevertheless, they faced high infection rates: 239,639 and 205,463 COVID-19 cases in Spain and Italy, respectively.

CONCLUSION

The precautionary actions might have played a role in limiting the spread of COVID-19 in several countries. However, many countries might not benefit from applying these indicators.

摘要

背景

2019年冠状病毒病(COVID-19)大流行对许多国家产生了负面影响,尤其是在医疗保健和金融系统方面。许多国家试图采取预防措施来应对这一流行病。本研究旨在探索和评估六大洲175个国家为预防严重急性呼吸综合征冠状病毒2(SARS-CoV-2)传播而采取的早期预防行动。

方法

基于2019年12月31日至2020年4月底收集的数据进行了一项利用现有公共数据的观察性研究,然后与2021年1月的数据进行比较。提取了若干数据,包括与SARS-CoV-2首例报告病例日期、确诊病例总数、活跃病例总数等相关的信息。此外,使用了七个经过验证的指标来评估各国的准备情况和预防行动。

结果

该研究共纳入175个国家。从3月到4月,北美和欧洲的COVID-19总感染率呈指数级快速上升。各国预防措施(指标)的应用情况各不相同。学校关闭、隔离和宵禁是所有国家中应用最多的指标。至于指标与其对感染率的影响之间的关系,意大利和西班牙是欧洲采取所有指标的领先国家。然而,它们面临着高感染率:西班牙和意大利分别有239,639例和205,463例COVID-19病例。

结论

预防行动可能在一些国家限制COVID-19传播方面发挥了作用。然而,许多国家可能并未从应用这些指标中受益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7ea/8180468/592e1a54b146/gr7a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7ea/8180468/926d3b62a15b/gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7ea/8180468/a8000df48943/gr2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7ea/8180468/0371abf7ae5e/gr3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7ea/8180468/26abf937ddcb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7ea/8180468/1104550dad2b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7ea/8180468/6bf5120f755e/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7ea/8180468/592e1a54b146/gr7a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7ea/8180468/926d3b62a15b/gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7ea/8180468/a8000df48943/gr2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7ea/8180468/0371abf7ae5e/gr3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7ea/8180468/26abf937ddcb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7ea/8180468/1104550dad2b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7ea/8180468/6bf5120f755e/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7ea/8180468/592e1a54b146/gr7a.jpg

相似文献

1
Are countries' precautionary actions against COVID-19 effective? An assessment study of 175 countries worldwide.各国针对新冠疫情的预防措施有效吗?一项对全球175个国家的评估研究。
Saudi Pharm J. 2021 May;29(5):391-409. doi: 10.1016/j.jsps.2021.03.011. Epub 2021 Apr 20.
2
Importance of early precautionary actions in avoiding the spread of COVID-19: Saudi Arabia as an Example.早期预防措施在避免新冠病毒传播中的重要性:以沙特阿拉伯为例。
Saudi Pharm J. 2020 Jul;28(7):898-902. doi: 10.1016/j.jsps.2020.05.005. Epub 2020 May 22.
3
Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.封锁对欧洲和北美 7 个国家的新冠病毒病死率和病毒突变传播的影响。
J Transl Med. 2020 Sep 2;18(1):338. doi: 10.1186/s12967-020-02501-x.
4
The heterogeneity of the COVID-19 pandemic and national responses: an explanatory mixed-methods study.新冠疫情的异质性与各国应对措施:一项解释性混合方法研究。
BMC Public Health. 2021 May 1;21(1):835. doi: 10.1186/s12889-021-10885-8.
5
[Analysis of the development trend and severity of the COVID-19 panidemic in the global world].[全球新冠疫情的发展趋势与严重程度分析]
Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Jun 18;53(3):536-542. doi: 10.19723/j.issn.1671-167X.2021.03.016.
6
Modeling and tracking Covid-19 cases using Big Data analytics on HPCC system platformm.在惠普高性能计算集群(HPCC)系统平台上使用大数据分析对新冠病毒疾病(Covid-19)病例进行建模和追踪。
J Big Data. 2021;8(1):33. doi: 10.1186/s40537-021-00423-z. Epub 2021 Feb 15.
7
SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis.东亚和太平洋地区的 SARS-CoV-2 第二波监测:纵向趋势分析。
J Med Internet Res. 2021 Feb 1;23(2):e25454. doi: 10.2196/25454.
8
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
9
First Wave of COVID-19 Pandemic in Italy: Data and Evidence.意大利的 COVID-19 大流行第一波:数据和证据。
Adv Exp Med Biol. 2021;1353:91-113. doi: 10.1007/978-3-030-85113-2_6.
10
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.撒哈拉以南非洲的新冠病毒监测系统:关于持续存在和传播以指导政策的建模研究
J Med Internet Res. 2020 Nov 19;22(11):e24248. doi: 10.2196/24248.

引用本文的文献

1
Intimate partner violence and associated factors among women during the COVID-19 pandemic in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚新冠疫情期间女性亲密伴侣暴力行为及其相关因素:一项系统综述与荟萃分析
Front Glob Womens Health. 2024 Aug 23;5:1425176. doi: 10.3389/fgwh.2024.1425176. eCollection 2024.
2
COVID-19 vaccine hesitancy among healthcare workers in Arab Countries: A systematic review and meta-analysis.阿拉伯国家医护人员对 COVID-19 疫苗的犹豫:系统评价和荟萃分析。
PLoS One. 2024 Jan 2;19(1):e0296432. doi: 10.1371/journal.pone.0296432. eCollection 2024.
3
The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the World.

本文引用的文献

1
Effects of the spread of COVID-19 on public health of polluted cities: results of the first wave for explaining the dejà vu in the second wave of COVID-19 pandemic and epidemics of future vital agents.新冠疫情对污染城市公众健康的影响:解释第二波新冠疫情和未来重要病原体疫情“似曾相识”的第一波结果。
Environ Sci Pollut Res Int. 2021 Apr;28(15):19147-19154. doi: 10.1007/s11356-020-11662-7. Epub 2021 Jan 4.
2
Inferring the effectiveness of government interventions against COVID-19.推断政府干预 COVID-19 的效果。
Science. 2021 Feb 19;371(6531). doi: 10.1126/science.abd9338. Epub 2020 Dec 15.
3
How do low wind speeds and high levels of air pollution support the spread of COVID-19?
严重急性呼吸综合征冠状病毒2型免疫状态和社会限制措施对全球控制2019冠状病毒病的影响。
Vaccines (Basel). 2023 Aug 23;11(9):1407. doi: 10.3390/vaccines11091407.
4
Comparative study of COVID-19 situation between lower-middle-income countries in the eastern Mediterranean region.东地中海区域中低收入国家间新冠疫情的比较研究
J Oral Biol Craniofac Res. 2022 Jan-Feb;12(1):165-176. doi: 10.1016/j.jobcr.2021.10.004. Epub 2021 Oct 9.
5
What does COVID-19 testing results really say? The real statistics concealed behind the accessible data.新冠病毒检测结果到底说明了什么?可获取数据背后隐藏的真实统计数据。
J Med Virol. 2021 Oct;93(10):5977-5987. doi: 10.1002/jmv.27173. Epub 2021 Jul 20.
低风速和高空气污染水平如何助长新冠病毒的传播?
Atmos Pollut Res. 2021 Jan;12(1):437-445. doi: 10.1016/j.apr.2020.10.002. Epub 2020 Oct 7.
4
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的疗效。
N Engl J Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056/NEJMoa2022926. Epub 2020 Oct 8.
5
The effect of control measures on COVID-19 transmission in Italy: Comparison with Guangdong province in China.控制措施对意大利 COVID-19 传播的影响:与中国广东省的比较。
Infect Dis Poverty. 2020 Sep 16;9(1):130. doi: 10.1186/s40249-020-00730-2.
6
An index to quantify environmental risk of exposure to future epidemics of the COVID-19 and similar viral agents: Theory and practice.定量评估未来 COVID-19 和类似病毒暴露的环境风险的指标:理论与实践。
Environ Res. 2020 Dec;191:110155. doi: 10.1016/j.envres.2020.110155. Epub 2020 Aug 29.
7
Timing matters: the impact of response measures on COVID-19-related hospitalization and death rates in Germany and Switzerland.时机很重要:应对措施对德国和瑞士新冠肺炎相关住院率和死亡率的影响。
Swiss J Econ Stat. 2020;156(1):10. doi: 10.1186/s41937-020-00054-w. Epub 2020 Aug 26.
8
A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes.一项国家级分析,衡量政府行动、国家准备情况和社会经济因素对新冠肺炎死亡率及相关健康结果的影响。
EClinicalMedicine. 2020 Aug;25:100464. doi: 10.1016/j.eclinm.2020.100464. Epub 2020 Jul 21.
9
RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.撤稿:羟氯喹治疗 COVID-19 的多中心随机对照研究。
Am J Trop Med Hyg. 2020 Oct;103(4):1635-1639. doi: 10.4269/ajtmh.20-0873.
10
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.羟氯喹或联合阿奇霉素治疗轻中度 COVID-19。
N Engl J Med. 2020 Nov 19;383(21):2041-2052. doi: 10.1056/NEJMoa2019014. Epub 2020 Jul 23.